Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis
SARS-CoV-2 감염 진단을 위한 신속 IgM-IgG 복합항체 검사 개발 및 임상적용
Research Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
addition
Antibody test
Asymptomatic
Asymptomatic carrier
Asymptomatic carriers
Blood
blood sample
Blood samples
can be used
carried
carriers
Chain Reaction
China
Clinical diagnosis
Clinical efficacy
Clinical studies
clinical study
clinics
collected
coronavirus
coronavirus disease
COVID‐19
COVID‐19 patient
COVID‐19
detect
Detection sensitivity
development
Diagnosis
eight
evaluated
fingerstick blood
hospitals
identify
IgG antibodies
IgG antibody
IgG test
IgM
Immunoglobulin
immunoglobulin M
indicated
infected patients
Infection
lateral flow immunoassay
limitations
negative patients
Novel coronavirus
novel coronavirus disease
nucleic acid
nucleic acid real‐time polymerase chain reaction
number of infected
outbreak
Patient
patients
PCR
plasma
point‐of‐care
point‐of‐care testing
polymerase chain
polymerase chain reaction
Prevent
rapid IgM‐IgG combined test
Rapid test
real‐time PCR test
reported
respiratory
SARS‐CoV‐2
SARS‐CoV‐2 infection
SARS‐CoV‐2 virus
SARS‐CoV‐2 virus infection
sensitivity
serum
serum and plasma
severe acute respiratory syndrome Coronavirus
specificity
Spread
stages
symptomatic
Treatment
utility
venous
venous blood
virus
virus transmission
were measured
[DOI] 10.1002/jmv.25727 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1002/jmv.25727 PMC 바로가기 [Article Type] Research Article